title: Newborn Screening for Lysosomal Storage Disorders: Quo Vadis?
authors.affiliation: Associate Medical Director, Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA; roy.peake@childrens.harvard.edu.
authors.forename: Roy W A
authors.initials: RW
authors.lastname: Peake
authors.affiliation: Assistant Professor, Division of Genetics and Metabolism, Boston Children's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Marsden
authors.affiliation: Park Gerald Chair in Genetics and Genomics, Associate Chief, Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Olaf A
authors.initials: OA
authors.lastname: Bodamer
authors.affiliation: Professor and Boris and Barbara L. Weinstein Endowed Chair in Chemistry, Adjunct Professor of Biochemistry, Department of Chemistry, University of Washington, Seattle, WA.
authors.forename: Michael H
authors.initials: MH
authors.lastname: Gelb
authors.affiliation: Emeritus Medical Research Professor of Pediatrics, Duke University Health System, Durham, NC.
authors.forename: David S
authors.initials: DS
authors.lastname: Millington
authors.affiliation: Head of the Division of Metabolic Diseases, Academic Medical Centre, Emma Children's Hospital, University of Amsterdam, Amsterdam, The Netherlands.
authors.forename: Frits
authors.initials: F
authors.lastname: Wijburg
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D007231:Infant, Newborn; D016464:Lysosomal Storage Diseases / Q000175:diagnosis* / Q000628:therapy; D015997:Neonatal Screening / Q000191:economics / Q000706:statistics & numerical data*